(BBDC) Barings BDC - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US06759L1035
Stock: Senior Loans, Unitranche Debt, Subordinated Debt, Equity Co-Investments
Total Rating 27
Risk 66
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 17.9% |
| Relative Tail Risk | -1.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -21.03 |
| Character TTM | |
|---|---|
| Beta | 0.558 |
| Beta Downside | 1.074 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.45% |
| CAGR/Max DD | 0.48 |
EPS (Earnings per Share)
Revenue
Description: BBDC Barings BDC February 27, 2026
Barings BDC, Inc. (NYSE: BBDC) is an externally managed business development company that focuses on senior secured and mezzanine financing for U.S. middle-market companies. Its portfolio targets firms with EBITDA of $10 million–$75 million and revenues up to $200 million, spanning manufacturing, business services, technology, logistics and consumer sectors.
As of the most recent quarter (Q4 2025), BBDC reported a net asset value (NAV) of $13.42 per share and a dividend yield of roughly 9.1%, supported by a 93% weighted-average credit rating (B-) across its loan portfolio. The fund’s assets under management have grown to $1.6 billion, with 68% of investments in senior secured loans and the remainder in unitranche and equity co-investments.
Demand for private credit in the lower-middle market remains strong, driven by continued private-equity sponsor activity and a modestly tightening U.S. credit cycle that favors higher-yield, secured financing. Monitoring interest-rate trends and corporate earnings in the targeted EBITDA range will be key to assessing BBDC’s future performance.
For a deeper dive into the valuation and risk profile, you might explore additional data on ValueRay.
Headlines to watch out for
- Middle-market loan demand impacts investment volume
- Interest rate fluctuations affect net investment income
- Credit quality of portfolio companies drives asset value
- Regulatory changes for BDCs influence operational costs
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 101.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.13 > 1.0 |
| NWC/Revenue: 53.33% < 20% (prev 49.78%; Δ 3.54% < -1%) |
| CFO/TA 0.09 > 3% & CFO 250.2m > Net Income 101.9m |
| Net Debt (1.36b) to EBITDA (123.2m): 11.06 < 3 |
| Current Ratio: 3.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.2m) vs 12m ago -0.35% < -2% |
| Gross Margin: 71.77% > 18% (prev 0.62%; Δ 7.12k% > 0.5%) |
| Asset Turnover: 8.60% > 50% (prev 7.82%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 0.25 > 6 (EBITDA TTM 123.2m / Interest Expense TTM 85.1m) |
Altman Z'' -1.01
| A: 0.05 (Total Current Assets 164.2m - Total Current Liabilities 42.0m) / Total Assets 2.64b |
| B: -0.27 (Retained Earnings -702.3m / Total Assets 2.64b) |
| C: 0.01 (EBIT TTM 20.9m / Avg Total Assets 2.67b) |
| D: -0.48 (Book Value of Equity -702.2m / Total Liabilities 1.48b) |
| Altman-Z'' Score: -1.01 = CCC |
Beneish M
| DSRI: 0.68 (Receivables 41.4m/56.3m, Revenue 229.2m/210.9m) |
| GMI: 0.86 (GM 71.77% / 61.65%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.09 (Revenue 229.2m / 210.9m) |
| TATA: -0.06 (NI 101.9m - CFO 250.2m) / TA 2.64b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BBDC shares?
As of March 15, 2026, the stock is trading at USD 8.14 with a total of 811,623 shares traded.
Over the past week, the price has changed by -1.70%, over one month by -8.22%, over three months by -6.78% and over the past year by -4.62%.
Over the past week, the price has changed by -1.70%, over one month by -8.22%, over three months by -6.78% and over the past year by -4.62%.
Is BBDC a buy, sell or hold?
Barings BDC has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy BBDC.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BBDC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.8 | 20.4% |
| Analysts Target Price | 9.8 | 20.4% |
BBDC Fundamental Data Overview March 12, 2026
P/E Trailing = 8.4227
P/E Forward = 7.9114
P/S = 3.0638
P/B = 0.7352
P/EG = 3.1449
Revenue TTM = 229.2m USD
EBIT TTM = 20.9m USD
EBITDA TTM = 123.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.36b USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (855.5m + Debt 1.43b - CCE 66.8m)
Interest Coverage Ratio = 0.25 (Ebit TTM 20.9m / Interest Expense TTM 85.1m)
EV/FCF = 8.87x (Enterprise Value 2.22b / FCF TTM 250.2m)
FCF Yield = 11.28% (FCF TTM 250.2m / Enterprise Value 2.22b)
FCF Margin = 109.2% (FCF TTM 250.2m / Revenue TTM 229.2m)
Net Margin = 44.48% (Net Income TTM 101.9m / Revenue TTM 229.2m)
Gross Margin = 71.77% ((Revenue TTM 229.2m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 85.59% (prev 80.22%)
Tobins Q-Ratio = 0.84 (Enterprise Value 2.22b / Total Assets 2.64b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.43b)
Taxrate = 5.02% (1.33m / 26.6m)
NOPAT = 19.8m (EBIT 20.9m * (1 - 5.02%))
Current Ratio = 3.91 (Total Current Assets 164.2m / Total Current Liabilities 42.0m)
Debt / Equity = 1.23 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 11.06 (Net Debt 1.36b / EBITDA 123.2m)
Debt / FCF = 5.45 (Net Debt 1.36b / FCF TTM 250.2m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.82% (Net Income 101.9m / Total Assets 2.64b)
RoE = 8.69% (Net Income TTM 101.9m / Total Stockholder Equity 1.17b)
RoCE = 0.80% (EBIT 20.9m / Capital Employed (Total Assets 2.64b - Current Liab 42.0m))
RoIC = 0.73% (NOPAT 19.8m / Invested Capital 2.71b)
WACC = 3.86% (E(855.5m)/V(2.29b) * Re(7.97%) + D(1.43b)/V(2.29b) * Rd(1.48%) * (1-Tc(0.05)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.57%
[DCF] Terminal Value 80.82% ; FCFF base≈197.2m ; Y1≈129.4m ; Y5≈59.1m
[DCF] Fair Price = 4.95 (EV 1.88b - Net Debt 1.36b = Equity 518.4m / Shares 104.7m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 14.94 | EPS CAGR: 4.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -7.73 | Revenue CAGR: 7.53% | SUE: -0.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.24 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=0.97 | Chg7d=-0.004 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=-13.2% | Growth Revenue=-11.7%
EPS next Year (2027-12-31): EPS=0.93 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=-4.8% | Growth Revenue=-1.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.9% (Discount Rate 8.0% - Earnings Yield 11.9%)
[Growth] Growth Spread = -12.8% (Analyst -16.7% - Implied -3.9%)
P/E Forward = 7.9114
P/S = 3.0638
P/B = 0.7352
P/EG = 3.1449
Revenue TTM = 229.2m USD
EBIT TTM = 20.9m USD
EBITDA TTM = 123.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.36b USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (855.5m + Debt 1.43b - CCE 66.8m)
Interest Coverage Ratio = 0.25 (Ebit TTM 20.9m / Interest Expense TTM 85.1m)
EV/FCF = 8.87x (Enterprise Value 2.22b / FCF TTM 250.2m)
FCF Yield = 11.28% (FCF TTM 250.2m / Enterprise Value 2.22b)
FCF Margin = 109.2% (FCF TTM 250.2m / Revenue TTM 229.2m)
Net Margin = 44.48% (Net Income TTM 101.9m / Revenue TTM 229.2m)
Gross Margin = 71.77% ((Revenue TTM 229.2m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 85.59% (prev 80.22%)
Tobins Q-Ratio = 0.84 (Enterprise Value 2.22b / Total Assets 2.64b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.43b)
Taxrate = 5.02% (1.33m / 26.6m)
NOPAT = 19.8m (EBIT 20.9m * (1 - 5.02%))
Current Ratio = 3.91 (Total Current Assets 164.2m / Total Current Liabilities 42.0m)
Debt / Equity = 1.23 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 11.06 (Net Debt 1.36b / EBITDA 123.2m)
Debt / FCF = 5.45 (Net Debt 1.36b / FCF TTM 250.2m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.82% (Net Income 101.9m / Total Assets 2.64b)
RoE = 8.69% (Net Income TTM 101.9m / Total Stockholder Equity 1.17b)
RoCE = 0.80% (EBIT 20.9m / Capital Employed (Total Assets 2.64b - Current Liab 42.0m))
RoIC = 0.73% (NOPAT 19.8m / Invested Capital 2.71b)
WACC = 3.86% (E(855.5m)/V(2.29b) * Re(7.97%) + D(1.43b)/V(2.29b) * Rd(1.48%) * (1-Tc(0.05)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.57%
[DCF] Terminal Value 80.82% ; FCFF base≈197.2m ; Y1≈129.4m ; Y5≈59.1m
[DCF] Fair Price = 4.95 (EV 1.88b - Net Debt 1.36b = Equity 518.4m / Shares 104.7m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 14.94 | EPS CAGR: 4.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -7.73 | Revenue CAGR: 7.53% | SUE: -0.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.24 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=0.97 | Chg7d=-0.004 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=-13.2% | Growth Revenue=-11.7%
EPS next Year (2027-12-31): EPS=0.93 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=-4.8% | Growth Revenue=-1.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.9% (Discount Rate 8.0% - Earnings Yield 11.9%)
[Growth] Growth Spread = -12.8% (Analyst -16.7% - Implied -3.9%)